<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/455203A4-9781-4725-A589-223CA5AD2E10"><gtr:id>455203A4-9781-4725-A589-223CA5AD2E10</gtr:id><gtr:name>Australian National University (ANU)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2C711771-B8F6-4CDF-9AC3-9FAB317463D9"><gtr:id>2C711771-B8F6-4CDF-9AC3-9FAB317463D9</gtr:id><gtr:name>University of Cape Town</gtr:name><gtr:address><gtr:line1>Private Bag</gtr:line1><gtr:line2>Rondebosch</gtr:line2><gtr:postCode>7700</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>South Africa</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/56281201-841A-4923-869D-2C45A3220F63"><gtr:id>56281201-841A-4923-869D-2C45A3220F63</gtr:id><gtr:name>Immunochemistry Research Unit</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/49FFE305-71E4-41B1-87AC-8E58220B1F28"><gtr:id>49FFE305-71E4-41B1-87AC-8E58220B1F28</gtr:id><gtr:name>Novartis Institutes for Biomedical Research (NIBR)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:department>Health Service Management Centre</gtr:department><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/455203A4-9781-4725-A589-223CA5AD2E10"><gtr:id>455203A4-9781-4725-A589-223CA5AD2E10</gtr:id><gtr:name>Australian National University (ANU)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2C711771-B8F6-4CDF-9AC3-9FAB317463D9"><gtr:id>2C711771-B8F6-4CDF-9AC3-9FAB317463D9</gtr:id><gtr:name>University of Cape Town</gtr:name><gtr:address><gtr:line1>Private Bag</gtr:line1><gtr:line2>Rondebosch</gtr:line2><gtr:postCode>7700</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>South Africa</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/56281201-841A-4923-869D-2C45A3220F63"><gtr:id>56281201-841A-4923-869D-2C45A3220F63</gtr:id><gtr:name>Immunochemistry Research Unit</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/49FFE305-71E4-41B1-87AC-8E58220B1F28"><gtr:id>49FFE305-71E4-41B1-87AC-8E58220B1F28</gtr:id><gtr:name>Novartis Institutes for Biomedical Research (NIBR)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/27712A22-4A77-441E-920C-DF224E26994E"><gtr:id>27712A22-4A77-441E-920C-DF224E26994E</gtr:id><gtr:firstName>Adam</gtr:firstName><gtr:otherNames>Fidelis</gtr:otherNames><gtr:surname>Cunningham</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0701275"><gtr:id>0AE33207-10A1-4510-A61A-F9A7B5BFC460</gtr:id><gtr:title>A bug in the system: how does Salmonella induce novel B cell responses?</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0701275</gtr:grantReference><gtr:abstractText>We are trying to understand how proteins called antibodies and the cells that make them work to protect against Salmonella infections. This should help improve vaccines against Salmonella and other bacteria since nearly all vaccines work via antibody. 
Salmonella infections can have deadly consequences killing hundreds of thousands around the world yearly. In some cases if Salmonella is found in an infant?s blood then that child has a near 25% chance of dying. 
Salmonella travels through the blood to infect and grow in many sites such as the liver or spleen. Yet the body is not defenceless against this spread because antibodies can bind Salmonella and lead to its killing. But to be effective the antibody needs to be present before the infection and this can be achieved by vaccination. 
Using a mouse model, since these complex events cannot be effectively mimicked in other systems, we have found that antibodies to some Salmonella proteins can prevent infection and may help us design an effective, safe vaccine. Since these Salmonella proteins and the cells that make the antibody have some unusual properties we hope that these studies may help us better understand how we fight bacteria and then use this information to design vaccines to other bacterial diseases.</gtr:abstractText><gtr:technicalSummary>Salmonella infections have deadly consequences. In sub-Saharan Africa non-typhoidal Salmonella infections (NTS) are a leading killer and the most susceptible groups are children 6 months but 24 months of age and HIV+ adults. Death is associated with bacteraemia in the absence of antibody, implicating antibody may be protective although the role of humoral responses in immunity to Salmonella has been controversial. Recently we published that Salmonella infection induces a novel antibody response characterized by a rapid, extensive T-independent extrafollicular (EF) response concomitant with accelerated T-dependent switching. This response is selective since switched antibody to outer membrane proteins (OMPs), but not LPS or flagellin, is detected early in the infection and occurs in the absence of germinal centres (GC) and associated high-affinity antibody and memory B cell formation. The antibody induced during the response reduces bacteraemia and subsequent colonization. We have extended these findings to show that antibody protects mice with defective cell-mediated immunity and that the proteins, OmpF and C, but not LPS induce a population of self-renewing B220intCD5- B1b B cells. This B1b population, the first identified to a protein antigen, offers strong protection against infection when transferred into B cell-deficient mice. This project aims to improve our understanding of the biology of the B cell response to Salmonella and how we can exploit this to improve vaccine design by using murine models of infection and protection. We will use immunohistology, confocal microscopy, cell sorting and PCR to identify the cell populations involved, the sites of their activities and their individual molecular signatures. We will identify the capacity of individual cell populations to contribute to protection by transferring different populations of cells into recipient mice. In particular we want to determine 1) How important are these B1b cells to the massive EF response induced by Salmonella? 2) How do T cells interact with these cells, are they responsible for the early switched antibody and do they form part of the GC response? 3) How can we improve the protection offered by vaccinating with these proteins? 4) What is the mechanism by which protection is conferred? Together this information will contribute to improving our understanding of basic immunological processes during bacterial infection and to developing vaccines against NTS infections.</gtr:technicalSummary><gtr:fund><gtr:end>2011-10-26</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-10-27</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>347312</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Australian National University (ANU)</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:department>College of Medicine, Biology &amp; Environment (CMBE)</gtr:department><gtr:description>Australian National University</gtr:description><gtr:id>A3734162-B25A-4FF7-9D95-379ADB4021E7</gtr:id><gtr:impact>PMID: 21708925</gtr:impact><gtr:outcomeId>MwmABmJ7HwP-1</gtr:outcomeId><gtr:partnerContribution>Publication in JEM</gtr:partnerContribution><gtr:piContribution>We worked together on different aspects of TfH development</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Immunochemistry Research Unit</gtr:collaboratingOrganisation><gtr:country>Mexico, United Mexican States</gtr:country><gtr:description>Mexico</gtr:description><gtr:id>1F7D59FF-1049-427E-AA23-D6308673F46F</gtr:id><gtr:impact>PNAS paper - 19487686
Science paper - 20413503

We are also collaborating on how best to take the OmpD vaccine forward. We hold the patent on OmpD and they hold the patent on the purification.</gtr:impact><gtr:outcomeId>B49D2BEA478-1</gtr:outcomeId><gtr:partnerContribution>Unique materials</gtr:partnerContribution><gtr:piContribution>The proteins provided were important for identifying the nature of the antibody response to Salmonella</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Immune Regulation</gtr:department><gtr:description>MRC Centre for Immune Regulation</gtr:description><gtr:id>AF65DF57-0F2C-4C57-9ADC-0DA4689EB245</gtr:id><gtr:impact>From this collaboration nearly all of my publications and patent are due, in part, to this collaboration.</gtr:impact><gtr:outcomeId>hLsN67onaDd-1</gtr:outcomeId><gtr:partnerContribution>Access to material and equipment as well as MRC students</gtr:partnerContribution><gtr:piContribution>Contribution to a theme in the Centre: Induction and regulation of immunity in secondary lymphoid tissues. My work examining how immune responses develop to pathogens and their components offers broad cross-theme collaborations.</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cape Town</gtr:collaboratingOrganisation><gtr:country>South Africa, Republic of</gtr:country><gtr:description>UCT</gtr:description><gtr:id>3398AE41-B73E-4B7E-BF6D-EF42E7C5193C</gtr:id><gtr:impact>doi: 10.1007/978-1-4939-1489-0_4
doi: 10.1371/journal.ppat.1003662
doi: 10.1371/journal.pntd.0003341</gtr:impact><gtr:outcomeId>5462493c9df098.04600228-1</gtr:outcomeId><gtr:partnerContribution>They have provided unique reagents and resources enabling us to conduct experiments and studies not possible in their absence.</gtr:partnerContribution><gtr:piContribution>We have published a number of papers together examining how antibody responses and vaccines work. We have conducted research visits to UCT to perform the work there and also collaborated by providing advice and reagents</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Novartis Institutes for BioMedical Research (NIBR)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Novartis Vaccines Institute for Global Health (NVGH)</gtr:department><gtr:description>NVGH</gtr:description><gtr:id>1230DF51-E4B4-45A3-BBD4-FEF4D6F48D6F</gtr:id><gtr:impact>The development of OmpD as a vaccine. NVGH have taken licec of the patent protecting this work. The project is multi-disciplinary as it covers biology and chemistry.</gtr:impact><gtr:outcomeId>SuxfsLzPzx5-1</gtr:outcomeId><gtr:partnerContribution>Publications and the use of industrial skills to develop our vaccine against non-typhoidal Salmonella</gtr:partnerContribution><gtr:piContribution>We identified the vaccine target and I have been involved in helping develop aspects of the immunological side of the collaboration</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Sanger</gtr:description><gtr:id>1F709083-60FE-49EB-B79C-E370A8C217F8</gtr:id><gtr:impact>PNAS paper - 19487686
Science paper - 20413503</gtr:impact><gtr:outcomeId>45DF1B853AE-1</gtr:outcomeId><gtr:partnerContribution>Gene-deficient bacteria</gtr:partnerContribution><gtr:piContribution>We used the bacteria to confirm our hypotheses regarding the protective nature of antigens

We have expanded the use of these bacteria to assess the major determinants of protection during Salmonella infection</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Southampton</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Medicine</gtr:department><gtr:description>Southampton</gtr:description><gtr:id>5C808577-5249-4630-B993-3E675E53D7BB</gtr:id><gtr:impact>CD11c paper Immunology - 20465572</gtr:impact><gtr:outcomeId>BmMEMjFszZL-1</gtr:outcomeId><gtr:partnerContribution>Intellectual input</gtr:partnerContribution><gtr:piContribution>We are working on ways that Salmonella interferes</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Radio interview</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>BA70415D-3130-4FA7-8FCC-E59992A42054</gtr:id><gtr:impact>Interview on Radio 4, discussing the implications of our work for a vaccine against Salmonella infection

Increased profile, liaisons with members of the public emailing me.</gtr:impact><gtr:outcomeId>A20C90F63FD</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>TV interview</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>F31B2B5C-1205-4DCA-9443-144C9A7DD9E1</gtr:id><gtr:impact>Interview with BBC Midlands Today, the Midlands BBC news programme

We highlighted the vaccine work undertaken in Birmingham</gtr:impact><gtr:outcomeId>oU6gffiVg6X</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Media agency telephone interview</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>A7924635-882E-4A20-991D-3DD1D10F5A74</gtr:id><gtr:impact>Interviewed by telephone regarding the impact of the research for vaccine development

I was invited to interview to Radio 4. The interview was also hosted on a number of websites and newspapers locally, nationally and internationally</gtr:impact><gtr:outcomeId>56A17EED9C8</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Secondary school student work experience</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>9CDD04FF-516F-4520-81E3-8B97EA5B9EEC</gtr:id><gtr:impact>1 student for work experience.

This has developed into a longer-term relationship. For instance, I will host another student next year and have arranged to talk at the school next year.</gtr:impact><gtr:outcomeId>pNEMgJCKCR4</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>school visit</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>BE5DDCE0-344D-42B5-85DD-432810A1549B</gtr:id><gtr:impact>Talks at local schools about animal experimentation and immunology, vaccinology and infectious disease. During this it became clear it is important alos to offer career advice. This is something also pursued by members of my group

Increased awareness and involvement with other schools</gtr:impact><gtr:outcomeId>DGFMHUSSmfm</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2010,2011,2012,2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>University media centre and alumni</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>FE9C4584-A129-4C89-A2A6-D71D6F2223C4</gtr:id><gtr:impact>Interviewed by telephone and generated a press release outlining the work and its importance as well as the clinical problem

Led to other interviews and contacts</gtr:impact><gtr:outcomeId>391EBB26E19</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Wellcome Trust Research Training Fellowship</gtr:department><gtr:description>wellcome trust CRF</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>DA70CB26-6881-404A-A0B4-B9B3D74CF78C</gtr:id><gtr:outcomeId>54624c7ade4fd2.36883823</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1075000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>European Industrial Doctorate</gtr:description><gtr:end>2016-03-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>E4EF4D04-A804-45BF-80B2-A8D81CAEEBA0</gtr:id><gtr:outcomeId>UrYRQdJbHut</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>That the protein OmpD can be used as the whole or part of a vaccine againstnon-typhoidal Salmonella infection</gtr:description><gtr:grantRef>G0701275</gtr:grantRef><gtr:id>F06B8DEE-6850-416C-8BC4-AEAED7842295</gtr:id><gtr:impact>This has now been licenced to Novartis Vaccines for Global Health</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>0515EDB6468</gtr:outcomeId><gtr:patentId>WO2010029293</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>NTS OmpD vaccine</gtr:title><gtr:yearProtectionGranted>2010</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Science paper - non-typhoidal Salmonella in those with HIV</gtr:description><gtr:geographicReach>Africa</gtr:geographicReach><gtr:id>4551DB8D-1260-429B-8C50-38B1F2DE9289</gtr:id><gtr:outcomeId>j3wMQRi9h7v</gtr:outcomeId><gtr:type>Citation in clinical reviews</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>A vaccine against non-typhoidal Salmonella infection</gtr:description><gtr:id>ECB35DCC-ADDC-4DBA-B378-31B3DFE0B285</gtr:id><gtr:impact>This is being developed by Novartis Vaccines for Global Health</gtr:impact><gtr:outcomeId>8BA43345126</gtr:outcomeId><gtr:stage>Refinement.  Non-clinical</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>NTS OmpD vaccine</gtr:title><gtr:type>Therapeutic Intervention - Vaccines</gtr:type><gtr:yearDevCompleted>2009</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>08CBDDCA-3016-45E5-893D-32F7E18E235B</gtr:id><gtr:title>Dendritic cells and monocyte/macrophages that create the IL-6/APRIL-rich lymph node microenvironments where plasmablasts mature.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8722cf85af88fedef71a8a5f75ecdf1"><gtr:id>a8722cf85af88fedef71a8a5f75ecdf1</gtr:id><gtr:otherNames>Mohr E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>1ABA42ECF2E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D08A44C5-AD99-4DB0-A319-0B3D409E9E87</gtr:id><gtr:title>Ligation of CD11c during vaccination promotes germinal centre induction and robust humoral responses without adjuvant.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13f025c79f290c17f74a3168f2857f3f"><gtr:id>13f025c79f290c17f74a3168f2857f3f</gtr:id><gtr:otherNames>White AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>UHqcXjG9WB4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4BA63443-963E-4572-8A84-FC39491E3077</gtr:id><gtr:title>Helios is associated with CD4 T cells differentiating to T helper 2 and follicular helper T cells in vivo independently of Foxp3 expression.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b14b0373aa1adb274ac1a893a1bc537d"><gtr:id>b14b0373aa1adb274ac1a893a1bc537d</gtr:id><gtr:otherNames>Serre K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>VXvqG5195FM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57D64C1E-EECC-4D3B-ADDF-0780CE3D3BAC</gtr:id><gtr:title>Soluble flagellin, FliC, induces an Ag-specific Th2 response, yet promotes T-bet-regulated Th1 clearance of Salmonella typhimurium infection.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/090770ae85e08aea4f8baa330abeb34d"><gtr:id>090770ae85e08aea4f8baa330abeb34d</gtr:id><gtr:otherNames>Bobat S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>hsHc9HWQs8Z</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8495054-FDD7-465C-835D-C054C4A78DFA</gtr:id><gtr:title>SadA, a trimeric autotransporter from Salmonella enterica serovar Typhimurium, can promote biofilm formation and provides limited protection against infection.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b7f3c5ac0ed294dcd0579e4e10906042"><gtr:id>b7f3c5ac0ed294dcd0579e4e10906042</gtr:id><gtr:otherNames>Raghunathan D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn><gtr:outcomeId>FsVKTtH4z2S</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F23EBF2D-8D37-4D81-888E-FDBD2F39BFA4</gtr:id><gtr:title>CD8 T cells induce T-bet-dependent migration toward CXCR3 ligands by differentiated B cells produced during responses to alum-protein vaccines.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b14b0373aa1adb274ac1a893a1bc537d"><gtr:id>b14b0373aa1adb274ac1a893a1bc537d</gtr:id><gtr:otherNames>Serre K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>pm_16204_24_23065152</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>481E95F2-92BD-4A37-9D48-1B2030DBC699</gtr:id><gtr:title>Increased severity of respiratory infections associated with elevated anti-LPS IgG2 which inhibits serum bactericidal killing.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13c2577848dab04a02b2b7f8e57a297d"><gtr:id>13c2577848dab04a02b2b7f8e57a297d</gtr:id><gtr:otherNames>Wells TJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>54624304786ef2.72955597</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>731D4360-2914-438D-8C35-22376096CBFF</gtr:id><gtr:title>T-zone localized monocyte-derived dendritic cells promote Th1 priming to Salmonella.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47167a5a3616b6be880b3d2e16a7ecb3"><gtr:id>47167a5a3616b6be880b3d2e16a7ecb3</gtr:id><gtr:otherNames>Flores-Langarica A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>Hb1x47pktY9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BDCF8E09-168B-466E-84FB-CC0BC360F37B</gtr:id><gtr:title>Differential Killing of Salmonella enterica Serovar Typhi by Antibodies Targeting Vi and Lipopolysaccharide O:9 Antigen.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25fd330244e67263d95f007b9964721b"><gtr:id>25fd330244e67263d95f007b9964721b</gtr:id><gtr:otherNames>Hart PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56e009a051ff54.04609893</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2FD0C95D-CF08-406D-9AD7-DEDC76364CD3</gtr:id><gtr:title>Inflammation drives thrombosis after Salmonella infection via CLEC-2 on platelets.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12aaff51ab345feb7fcf8bb4be590360"><gtr:id>12aaff51ab345feb7fcf8bb4be590360</gtr:id><gtr:otherNames>Hitchcock JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>56e009a011ad19.32901972</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>56C0A88C-9CDA-40EF-8560-77CD319556AD</gtr:id><gtr:title>Differential timing of antibody-mediated phagocytosis and cell-free killing of invasive African Salmonella allows immune evasion.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/228b8552733022b0a8c1779f91099f6e"><gtr:id>228b8552733022b0a8c1779f91099f6e</gtr:id><gtr:otherNames>Siggins MK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>5462430426c5b6.53283029</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D3FE5B1B-4BC4-4129-A7C4-1822C5E5328A</gtr:id><gtr:title>The porin OmpD from nontyphoidal Salmonella is a key target for a protective B1b cell antibody response.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac7a6d7d0e33498ac7e643f15a8a12b9"><gtr:id>ac7a6d7d0e33498ac7e643f15a8a12b9</gtr:id><gtr:otherNames>Gil-Cruz C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>9CDD02DF37C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F10C68B3-7F6E-46B8-997F-DC79F7B88ABF</gtr:id><gtr:title>The stability of complement-mediated bactericidal activity in human serum against Salmonella.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f709a9e9b1fae073725cbf344e3ddb33"><gtr:id>f709a9e9b1fae073725cbf344e3ddb33</gtr:id><gtr:otherNames>O'Shaughnessy CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_16204_24_23145102</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B4A204C-AB10-4528-9FED-D20E726D441E</gtr:id><gtr:title>Selective effects of NF-?B1 deficiency in CD4? T cells on Th2 and TFh induction by alum-precipitated protein vaccines.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b14b0373aa1adb274ac1a893a1bc537d"><gtr:id>b14b0373aa1adb274ac1a893a1bc537d</gtr:id><gtr:otherNames>Serre K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>AFkDqeTeBnF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57649F4D-9A93-4A18-BCF9-0BFC71ABA8D1</gtr:id><gtr:title>IL-4 directs both CD4 and CD8 T cells to produce Th2 cytokines in vitro, but only CD4 T cells produce these cytokines in response to alum-precipitated protein in vivo.</gtr:title><gtr:parentPublicationTitle>Molecular immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b14b0373aa1adb274ac1a893a1bc537d"><gtr:id>b14b0373aa1adb274ac1a893a1bc537d</gtr:id><gtr:otherNames>Serre K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0161-5890</gtr:issn><gtr:outcomeId>ct4J4vFxEfh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6427E59E-7538-4E14-9B80-3A833F8B4C1B</gtr:id><gtr:title>Death receptor 3 is essential for generating optimal protective CD4? T-cell immunity against Salmonella.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b09809cb8afe33cffca89350d4755b5"><gtr:id>8b09809cb8afe33cffca89350d4755b5</gtr:id><gtr:otherNames>Buchan SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>pm_16204_24_22259035</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4496A00-B891-4C48-AA32-58D5E6D4E348</gtr:id><gtr:title>Bacterial infections and vaccines.</gtr:title><gtr:parentPublicationTitle>Advances in experimental medicine and biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/090770ae85e08aea4f8baa330abeb34d"><gtr:id>090770ae85e08aea4f8baa330abeb34d</gtr:id><gtr:otherNames>Bobat S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:isbn>978-1-4939-1488-3</gtr:isbn><gtr:issn>0065-2598</gtr:issn><gtr:outcomeId>546243076b14e8.06999261</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5104968E-40DB-40A5-BF92-8A2FAC01739E</gtr:id><gtr:title>Natural and vaccine-mediated immunity to Salmonella Typhimurium is impaired by the helminth Nippostrongylus brasiliensis.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/090770ae85e08aea4f8baa330abeb34d"><gtr:id>090770ae85e08aea4f8baa330abeb34d</gtr:id><gtr:otherNames>Bobat S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>546249669fbab8.52331914</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B66FD7A3-6749-40C1-9043-071ECD099009</gtr:id><gtr:title>Dysregulated humoral immunity to nontyphoidal Salmonella in HIV-infected African adults.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/826cdc2ce0980c0b971111b73991889a"><gtr:id>826cdc2ce0980c0b971111b73991889a</gtr:id><gtr:otherNames>MacLennan CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>dG9qD9zTo9g</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DAF0E895-033F-48DE-B38B-ABF85BC2C5F5</gtr:id><gtr:title>IFN-{gamma} produced by CD8 T cells induces T-bet-dependent and -independent class switching in B cells in responses to alum-precipitated protein vaccine.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8722cf85af88fedef71a8a5f75ecdf1"><gtr:id>a8722cf85af88fedef71a8a5f75ecdf1</gtr:id><gtr:otherNames>Mohr E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>LcL166RiGYN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30FA3BE7-5883-478A-9FC0-F5E6CED32848</gtr:id><gtr:title>Systemic flagellin immunization stimulates mucosal CD103+ dendritic cells and drives Foxp3+ regulatory T cell and IgA responses in the mesenteric lymph node.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47167a5a3616b6be880b3d2e16a7ecb3"><gtr:id>47167a5a3616b6be880b3d2e16a7ecb3</gtr:id><gtr:otherNames>Flores-Langarica A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>doi_53d08908907c6314</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30B6CC51-E341-44C7-A2EC-B3639CC447C5</gtr:id><gtr:title>IL-4Ra-associated antigen processing by B cells promotes immunity in Nippostrongylus brasiliensis infection.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbbd681e64166bf3d712ed49d8e003b5"><gtr:id>cbbd681e64166bf3d712ed49d8e003b5</gtr:id><gtr:otherNames>Horsnell WG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>546243040102f0.79652689</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4DE9EAC-A17C-4BE5-9A43-9B726869B871</gtr:id><gtr:title>Resolving Salmonella infection reveals dynamic and persisting changes in murine bone marrow progenitor cell phenotype and function.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8815e62a6f3fd63500acb52e99dbbeb"><gtr:id>a8815e62a6f3fd63500acb52e99dbbeb</gtr:id><gtr:otherNames>Ross EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>546243044b7477.06008544</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E88C790-F874-45EC-8A4E-BC8F64959BBD</gtr:id><gtr:title>The capsular polysaccharide Vi from Salmonella typhi is a B1b antigen.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38e50117f77a619640c23aad9a8a1599"><gtr:id>38e50117f77a619640c23aad9a8a1599</gtr:id><gtr:otherNames>Marshall JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>doi_53d08908904cea99</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C401FDD8-5EAC-4033-A312-2B85D0CFBBA4</gtr:id><gtr:title>B cell priming for extrafollicular antibody responses requires Bcl-6 expression by T cells.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c3d53c32a07327b4e6d48d4dc4a5a3c3"><gtr:id>c3d53c32a07327b4e6d48d4dc4a5a3c3</gtr:id><gtr:otherNames>Lee SK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>BcSc3TX7FMp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36466653-75BD-4134-B070-7C40BDE8B7FE</gtr:id><gtr:title>Trypanosoma cruzi infection induces a massive extrafollicular and follicular splenic B-cell response which is a high source of non-parasite-specific antibodies.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4dce13cc010bb3f4831e18fc3d685caf"><gtr:id>4dce13cc010bb3f4831e18fc3d685caf</gtr:id><gtr:otherNames>Bermejo DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>mN2tCUWZu57</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5FFAD0F-E25D-4367-B133-FA283B4E9033</gtr:id><gtr:title>B1b cells recognize protective antigens after natural infection and vaccination.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ff27e2ac4df3054f0117b04cf415acb"><gtr:id>7ff27e2ac4df3054f0117b04cf415acb</gtr:id><gtr:otherNames>Cunningham AF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>546243078f7676.32327482</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1682108-F74C-48C2-8F72-F009CD08AF95</gtr:id><gtr:title>Absent bactericidal activity of mouse serum against invasive African nontyphoidal Salmonella results from impaired complement function but not a lack of antibody.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/228b8552733022b0a8c1779f91099f6e"><gtr:id>228b8552733022b0a8c1779f91099f6e</gtr:id><gtr:otherNames>Siggins MK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>SG5BT1ZEgL5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>370A5DDB-E6E4-4A35-8DBF-3C0DA0F16751</gtr:id><gtr:title>Early B blasts acquire a capacity for Ig class switch recombination that is lost as they become plasmablasts.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38e50117f77a619640c23aad9a8a1599"><gtr:id>38e50117f77a619640c23aad9a8a1599</gtr:id><gtr:otherNames>Marshall JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>SH6mEeVMR7P</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>51796978-6BC1-45AA-9E7C-F07573B0E904</gtr:id><gtr:title>CD31 is required on CD4+ T cells to promote T cell survival during Salmonella infection.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8815e62a6f3fd63500acb52e99dbbeb"><gtr:id>a8815e62a6f3fd63500acb52e99dbbeb</gtr:id><gtr:otherNames>Ross EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>doi_53d0890890237a79</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0701275</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>D8F3A27D-084A-40BB-A046-087DACE23410</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>3.4  Vaccines</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>